Editorial: Pharmacological and Biochemical Perspectives of Kinase Inhibitors in Cancer and COVID-19 Therapeutics, Volume I

Front Pharmacol. 2022 Jun 15:13:916324. doi: 10.3389/fphar.2022.916324. eCollection 2022.
No abstract available

Keywords: CDK; COVID-19; kinase inhibitors; ligand-based and structure-based drug design; pharmacology.

Publication types

  • Editorial